A Pilot Study of Rimegepant in Moderate Plaque-type Psoriasis
Latest Information Update: 30 Aug 2023
At a glance
- Drugs Rimegepant (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 24 Aug 2023 Planned End Date changed from 1 Dec 2023 to 15 Aug 2024.
- 24 Aug 2023 Planned primary completion date changed from 1 Aug 2023 to 1 Aug 2024.
- 16 Sep 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.